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(Spon. by Michael W Partington) Prenatal exposure to ethanol producesacharacteristic phenotype and a constellation of nervous system abnormlities. Effects of ethanol on the developing nervous system occur during early neurogenesis when neuron-matrix interactions andprocess formation are proceeding.
An in vitro paradigm which quantitates both substrate interaction and process formation has been used to examine directly the effects of alcoholon embryonic neurons. Nerve Growth Factor (NGF) produces dose-dependent neurite outgrowthfrom responsive chick embryo neurons following attachment to anappropriate substrate (J Neurobiol12,175, 1981) . Ethanol and its metabolite acetaldehyde produced dose-dependent inhibition of NGF-induced neurite outgrowth. The 50% toxic dose (TD50) of ethanol was 175 mg/100ml (38mM) and the TD 50of acetaldehyde was 2.5mg/lOOml (0.6mM). No effects were seen on neuron attachment to the substrate or on neuron viability at 24hrs. These data suggest thatethanol is toxic to neuron process formation at concentrations considered moderate in the human circulation. Consistentwithin vivo experimental studies there was a rank order of toxicitywith acetaldehyde having greatertoxic effect thanethanol on a molar basis.
Ethanol may exert its toxic effects on neuronal developentby interfering with the ability ofneurons to respondto trophic influences within their environments. Further studies using this paradigm may contribute to an understanding of the teratogenic potential of alcohol, anticonvulsants and other xenobiotics. In 1974, Burgio eal. described pseudodiastrophic dysplasia (PDD) as a distinct neonatal skeletal dysplasia which superficially resembled diastrophic dysplasia (DD). The two sisters reported died in infancy of unexplained hyperthermia. A third case, reported by Canki in 1979, also died in infancy.
We wish to report three new, unrelated cases of PDD, including two children who have survived infancy, the oldest now 4 years old. Clinical features include: relative macrocephaly, flat midface, abnormal pinnae which do not undergo cystic enlargment, small chest, scoliosis, rhizomelia, flexion contractures of the hands, and club feet. Unique radiographic features include proximal interphalangeal joint dislocations and platyspondyly. The metacarpals are short but normally modelled. In the older children, the hand and foot abnormalities have improved with physical therapy alone, which also distinguishes PDD from DD. Scoliosis has been progressive, and the oldest child has recently undergone spinal rodding.
Morphologic examination of chondro-osseous growth plate of one of the original cases and our oldest patient revealed non-specific changes. The focal degeneration of cartilage with intracartilaginous ossification characteristic of DD was not seen. The pathogenesis of this unique, apparently autosomal recessive, neonatal skeletal dysplasia remains to be elucidated. . .
BLOOD DISORDERS AND CARDIAC MORPHOGENESIS. Charlotte
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An epidemiologic study of congenital heart disease (CHD) is in progress in the Baltimore-Washington area of 85,000 annual births. Infants with CHD are studied in comparison to a representative sample of the birth cohort. Family histories of 696 cases and 908 controls reveal heritable blood disorders (HBD) in 1% of CHD infants and/or parents, including hemophilia, von Willebrand's disease (v. W's), spherocytosis, thalassemia and sickle cell disease (SCD); only SCD occurred in 2 controls. Additional cases gathered from pediatric cardiologists and the literature suggest that transposition of the great arteries and valve lesions are predominant with HBD. An etiologicassociation is biologically plausible: cyanotic and acyanotic CHD occur with various coagulopathies and with familial fibrinogen and coagulation factor deficiencies; v. W's is linked with mitral valve prolapse and teleangiectasias.
Two possible morphogenic mechanisms include a gene induced alteration of early cardiac endothelium which also secretes factors VIII and v. W's (Jaffee, E.A., N. Engl. J. Med. 296:377, 1977) and/or alterations of osmosis of embryonic blood causing the teratogenic "edema syndrome" (Grabowski, C.T., J. Exp. 2001 Exp. . 157:307, 1964 
t describes t h r e e males and f o u r females i n t h r e e gene r a t i o n s o f a f a m i l y w i t h a new, p r o g r e s s i v e neuroectodermal syndrome. The p r i n c i p a l f e a t u r e s a r e : s e i z u r e (617); c e r e b r a l vasc u l a r a c c i d e n t (117); g e n e r a l i z e d h i r s u t i s m (717); l o w f r o n t a l h a i r l i n e and temporal p r o j e c t i o n o f s c a l p h a i r o n t o forehead (7/7X coarse f a c i e s (717); redundance o f s k i n o f t h e e y e l i d s (blepharoc h a l a s i s ) (517); t h i c k l i p s (617) h y p e r p l a s i a o f t i s s u e i n a n t e ri o r p a l a t a l r e g i o n (417) and c u t i s v e r t i c i s g y r a t a (517).
Abnorma l i t i e s a r e more marked i n males. No corneal leukoma, c l u b b i n g o f t h e d i g i t s , p e r i o s t o s i s o r mental r e t a r d a t i o n a r e present. Androgen p r o f i l e s and FSHILH r a t i o s i n t h e two cases t e s t e d a r e n o rmal. The occurrence o f t h i s d i s o r d e r i n t h r e e g e n e r a t i o n s w i t h male-to-male t r a n s m i s s i o n documents autosomal dominant i n h e r i t a n c e . n i a , and mental r e t a r d a t i o n which a r e n o t p r e s e n t i n o u r cases. G i n g i v a l f i b r o m a t o s i s -h y p e rt r i c h o s e s syndrome d i f f e r s by having e x t e n s i v e g i n g i v a l fibromat o s i s and mental r e t a r d a t i o n . Autosomal dominant syndrome o f c u t i s v e r t i c i s g y r a t a and t h i c k e n i n g o f t h e o r a l mucosa (Hughes, 1983) , has many f e a t u r e s i n common w i t h o u r cases b u t l a c k s h i r s u tism. We conclude t h a t o u r cases r e p r e s e n t a new syndrome. The purpose of this study was to report the effects of maternal PCP use on the fetus. 94 neonates whose mothers had a history of PCP exposure were compared with 94 control infants. Mothers of study and control patients were matched by maternal date of recruitment, ethnicity, weight, parity, weeks gestation at registration, and tobacco smoking behavior. PCP using women tended to be multiple drug abusers compared to non PCP users (mean number of drugs used 1.4t1.12 vs 0.6t0.8) [p< 0.0011. PCP use was assessed by questionnaire and repeated urine testing. Infant growth, neurological function, physical characteristics, behavior, and hospital course were assessed by a single examiner blind to the maternal history. Study infants had a mean of 4.5f2.7 abnormalities while control infants had a mean of 3.6t2.4 abnormalities [p (2 tailed)< 0.0051. Non parametric tests were used to determine which abnormalities differentiated the study from the control infants. Study infants were more likely to have poor attention, hypertonia, and depressed neonatal reflexes [p <.05] . Growth was normal and anatomic abnormalities were not found. The contribution of 7 classes of abused substances (narcotics, depressants, marijuana, stimulants, cocaine, glue, and alcohol) to the total number of abnormalities was assessed using stepwise multiple regression. Only PCP accounted for a significant percentage of the variance (f = 4.38; p < .05). This study indicates that maternal PCP alone may lead to abnormal neonatal neurobehavior.
EFFECT OF PHENCYCLIDINE (PCP
